Literature DB >> 7963688

Approaches to gene transfer in keratinocytes.

E S Fenjves1.   

Abstract

The introduction and expression of exogenous genetic material in cultured cells has provided a powerful tool for studying gene function and regulation. Immortalized cell lines have been useful for establishing gene transfer methodologies that are generally inefficient. For investigators of epidermal and mucosal biology, wishing to make use of the tissue architecture produced by primary keratinocytes in vitro, the limited life span of these cells presents a host of unique problems. Primary cells require the use of gene transfer methods that are highly efficient and will not significantly alter the cell's normal differentiation pathway. The purpose of this review is to evaluate gene transfer technology as it applies to keratinocytes.

Mesh:

Year:  1994        PMID: 7963688     DOI: 10.1111/1523-1747.ep12399089

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  4 in total

1.  Efficient in situ electroporation of mammalian cells grown on microporous membranes.

Authors:  T A Yang; W C Heiser; J M Sedivy
Journal:  Nucleic Acids Res       Date:  1995-08-11       Impact factor: 16.971

Review 2.  Cultivation of human keratinocyte stem cells: current and future clinical applications.

Authors:  G Pellegrini; S Bondanza; L Guerra; M De Luca
Journal:  Med Biol Eng Comput       Date:  1998-11       Impact factor: 2.602

3.  Keratinocyte gene therapy for systemic diseases. Circulating interleukin 10 released from gene-transferred keratinocytes inhibits contact hypersensitivity at distant areas of the skin.

Authors:  X Meng; D Sawamura; K Tamai; K Hanada; H Ishida; I Hashimoto
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

4.  Clonal analysis of stably transduced human epidermal stem cells in culture.

Authors:  M B Mathor; G Ferrari; E Dellambra; M Cilli; F Mavilio; R Cancedda; M De Luca
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.